CL2018002042A1 - Metodos para la produccion de virus. - Google Patents

Metodos para la produccion de virus.

Info

Publication number
CL2018002042A1
CL2018002042A1 CL2018002042A CL2018002042A CL2018002042A1 CL 2018002042 A1 CL2018002042 A1 CL 2018002042A1 CL 2018002042 A CL2018002042 A CL 2018002042A CL 2018002042 A CL2018002042 A CL 2018002042A CL 2018002042 A1 CL2018002042 A1 CL 2018002042A1
Authority
CL
Chile
Prior art keywords
virus
methods
japanese eel
cell culture
eel cell
Prior art date
Application number
CL2018002042A
Other languages
English (en)
Spanish (es)
Inventor
Lindsey Ann Toon
Ralf Hoffmann
Original Assignee
Benchmark Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1601861.6A external-priority patent/GB201601861D0/en
Application filed by Benchmark Animal Health Ltd filed Critical Benchmark Animal Health Ltd
Publication of CL2018002042A1 publication Critical patent/CL2018002042A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10061Methods of inactivation or attenuation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/30011Nodaviridae
    • C12N2770/30034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/30011Nodaviridae
    • C12N2770/30051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2796/00Viruses not covered by groups C12N2710/00 - C12N2795/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CL2018002042A 2016-02-02 2018-07-30 Metodos para la produccion de virus. CL2018002042A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1601861.6A GB201601861D0 (en) 2016-02-02 2016-02-02 Methods of producing viruses
GB201618549 2016-11-03

Publications (1)

Publication Number Publication Date
CL2018002042A1 true CL2018002042A1 (es) 2019-03-22

Family

ID=58018136

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002042A CL2018002042A1 (es) 2016-02-02 2018-07-30 Metodos para la produccion de virus.

Country Status (11)

Country Link
US (1) US10450544B2 (enExample)
EP (1) EP3411064B1 (enExample)
JP (1) JP2019511208A (enExample)
CN (1) CN109414494A (enExample)
AU (1) AU2017215287A1 (enExample)
BR (1) BR112018015527A2 (enExample)
CA (1) CA3011920A1 (enExample)
CL (1) CL2018002042A1 (enExample)
ES (1) ES2795040T3 (enExample)
SG (1) SG11201806182RA (enExample)
WO (1) WO2017134441A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111118171A (zh) * 2019-12-31 2020-05-08 广东省测试分析研究所(中国广州分析测试中心) 一种鉴别鱼翅种的dna条形码引物对、试剂盒及方法
CN113122510A (zh) * 2021-04-12 2021-07-16 中国水产科学研究院黑龙江水产研究所 一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
TWI220904B (en) * 1998-12-03 2004-09-11 Nat Science Council An immortal cell line derived from grouper Epinephelus coioides and its applications therein
TWI347364B (en) * 2003-02-19 2011-08-21 Novartis Ag Inactivated nodavirus vaccine
NO332608B1 (no) 2011-03-16 2012-11-19 Norwegian School Of Veterinary Science Levende avirulent IPNV og vaksine for profylakse eller behandling av IPN-sykdom hos fisk
CN104531608A (zh) * 2015-01-12 2015-04-22 福建省农业科学院生物技术研究所 一种欧洲鳗鲡肝脏细胞系及其构建方法和应用
CN105192298A (zh) * 2015-11-11 2015-12-30 浙江锦天生物科技有限公司 一种日本鳗鲡用复合微生态饲料添加剂

Also Published As

Publication number Publication date
WO2017134441A1 (en) 2017-08-10
BR112018015527A2 (pt) 2018-12-26
US10450544B2 (en) 2019-10-22
CA3011920A1 (en) 2017-08-10
EP3411064A1 (en) 2018-12-12
CN109414494A (zh) 2019-03-01
ES2795040T3 (es) 2020-11-20
SG11201806182RA (en) 2018-08-30
US20190040354A1 (en) 2019-02-07
AU2017215287A1 (en) 2018-08-16
EP3411064B1 (en) 2020-02-26
JP2019511208A (ja) 2019-04-25

Similar Documents

Publication Publication Date Title
AR094375A1 (es) Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular
AR100446A1 (es) Uso de moléculas pequeñas para mejorar la expresión de mafa en células endócrinas pancreáticas
CL2018002140A1 (es) Métodos y composiciones para aumentar la eficiencia de modificación genética dirigida usando reparación genética mediada por oligonucleótidos
MX2019012311A (es) Metodos y composiciones para modificaciones geneticas dirigidas y metodos de uso.
MX2018006373A (es) Produccion de virus en cultivos celulares.
EA201791443A1 (ru) Естественные киллерные клетки и их применения
CY1122791T1 (el) Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε ηπατοκυτταρο
MX2016006620A (es) Receptores de células t humanas con alta afinidad modificados por medio de manipulación genetica.
AR082820A1 (es) Diferenciacion de celulas madre embrionarias humanas
ECSP15011603A (es) Subunidades de vacunas de inmersión para peces
AR094389A1 (es) USO DE INHIBIDORES DE iNOS PARA AUMENTAR EL RENDIMIENTO VÍRICO EN CULTIVOS
MX373660B (es) Fibroblastos de embrion de pollo inmortalizados.
MX2017003651A (es) Métodos de establecimiento de bancos de células de densidad ultra-alta.
MX2014010482A (es) Metodo para la preparacion de vacunas de celulas dendriticas.
CL2020000734A1 (es) Expansión y uso de fracciones de células nk ampliadas.
MX2016013631A (es) Celulas huespedes modificadas y usos de las mismas.
CO2021013970A2 (es) Células t específicas del antígeno del virus multi-respiratorio y métodos para fabricar y usar el mismo terapéuticamente
AR105541A1 (es) ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR VRSh
AR069885A1 (es) Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional
CL2018002042A1 (es) Metodos para la produccion de virus.
EA202190758A1 (ru) Композиция для индукции гибели клеток, имеющих мутированный ген, и способ индукции гибели клеток, имеющих мутированный ген, с применением композиции
MX2018010283A (es) Metodo para producir factor de crecimiento de hepatocitos (hgf) activo.
AR072150A1 (es) Metodo de replicacion del virus de la influenza en suspension
BR112018010867A2 (pt) modelo de infecção de vírus, método de preparação do mesmo e utilização do mesmo
ES2663596T3 (es) Cepa de algas modificada y método de acumulación de triacilglicerol utilizando dicha cepa